U.S., Feb. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07429162) titled 'Bacteriophage for Chronic Multidrug-Resistant Mycobacterium Abscessus Subsp. Abscessus Pulmonary Infection' on Feb. 02.
Brief Summary: The objective of this study is to evaluate mycobacteriophage therapy using in-vitro validated mycobacteriophage DP-QB-MYA-002 in combination with conventional antimycobacterial agents for the treatment of multidrug-resistant Mycobacterium abscessus pulmonary disease, with the goal of reducing mycobacterial burden and improving pulmonary outcomes.
Study Start Date: July 02, 2026
Study Type: INTERVENTIONAL
Condition:
Mycobacterium Abscessus Infection
Bacteriophage Therapy
Pulmonary Disease
Interve...